--- title: "報道:諾華與羅氏即將達成美國藥價協議,瑞士貿易緊張局勢緩解" description: "據知情人士透露,白宮最早將於週五宣佈與製藥巨頭諾華公司和羅氏控股達成藥品定價協議,此舉將進一步緩解與瑞士的貿易緊張局勢。其他製藥商也可能出現在公告名單中;近幾個月來,輝瑞和阿斯利康等公司已簽署類似協議。作為降低美國藥價努力的一部分,這些企業同意削減成本,以換取關税豁免及潛在監管行動的緩解。(彭博)" type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/270049919.md" published_at: "2025-12-17T18:18:40.000Z" --- # 報道:諾華與羅氏即將達成美國藥價協議,瑞士貿易緊張局勢緩解 > 據知情人士透露,白宮最早將於週五宣佈與製藥巨頭諾華公司和羅氏控股達成藥品定價協議,此舉將進一步緩解與瑞士的貿易緊張局勢。其他製藥商也可能出現在公告名單中;近幾個月來,輝瑞和阿斯利康等公司已簽署類似協議。作為降低美國藥價努力的一部分,這些企業同意削減成本,以換取關税豁免及潛在監管行動的緩解。(彭博) 據知情人士透露,白宮最早將於週五宣佈與製藥巨頭諾華公司和羅氏控股達成藥品定價協議,此舉將進一步緩解與瑞士的貿易緊張局勢。其他製藥商也可能出現在公告名單中;近幾個月來,輝瑞和阿斯利康等公司已簽署類似協議。作為降低美國藥價努力的一部分,這些企業同意削減成本,以換取關税豁免及潛在監管行動的緩解。(彭博) ### Related Stocks - [RHHBY.US - 羅氏(ADR)](https://longbridge.com/zh-HK/quote/RHHBY.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Rovi jumps after announcing drug deal with Roche | Shares in Rovi rose about 8% following the announcement of a drug manufacturing deal with Roche. The agreement is expect | [Link](https://longbridge.com/zh-HK/news/262092937.md) | | Obesity challenger Roche 'only scratching surface' of market potential, says CEO | Roche's CEO, Thomas Schinecker, expressed confidence in the growth potential of the weight-loss drug market, stating the | [Link](https://longbridge.com/zh-HK/news/262356985.md) | | Did Analyst Upgrades and Metal Price Tailwinds Just Shift Coeur Mining's (CDE) Investment Narrative? | Recent analyst upgrades for Coeur Mining, alongside rising gold and silver prices, have shifted focus on the company's c | [Link](https://longbridge.com/zh-HK/news/275995095.md) | | Manappuram Finance Says RBI Grants Approval For Bain Capital To Acquire Joint Control In Co | Manappuram Finance Ltd :MANAPPURAM FINANCE LTD - RBI GRANTS APPROVAL FOR BAIN CAPITAL TO ACQUIRE JOINT CONTROL IN MANAPP | [Link](https://longbridge.com/zh-HK/news/275983986.md) | | Aberdeen Group plc Has $144.09 Million Position in Arista Networks, Inc. $ANET | Aberdeen Group plc increased its stake in Arista Networks, Inc. by 1.4% in Q3, owning 1,005,027 shares valued at $144.09 | [Link](https://longbridge.com/zh-HK/news/275999141.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。